HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi

Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

NCT05659251 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

The Microbiome of Oesophageal Squamous Cell Carcinoma

NCT04425122 ·Status: UNKNOWN

Investigating the Association Between Microbiota and Esophageal/Oropharyngeal Cancer

NCT05412628 ·Status: UNKNOWN ·Phase: NA

Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer

NCT06306755 ·Status: RECRUITING ·Phase: NA

A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western Kenya

NCT00901173 ·Status: COMPLETED

Endoscopic Screening on Esophageal Cancer

NCT02094105 ·Status: COMPLETED ·Phase: NA

Risk Factors of Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to Neoadjuvant Chemoradiotherapy

NCT06061263 ·Status: UNKNOWN

Detection of Circulating Tumor Tells as The Guidance of the Neoadjuvant Chemotherapy of Esophageal Cancer

NCT03005314 ·Status: UNKNOWN ·Phase: NA

Treatment Outcomes of Esophageal Cancer

NCT05177393 ·Status: RECRUITING

Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC

NCT05807542 ·Status: COMPLETED ·Phase: PHASE2

Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus

NCT00766480 ·Status: UNKNOWN ·Phase: NA

Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC)

NCT01688908 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Esophageal Arterial Infusion Chemotherapy Versus Systemic Intravenous Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Prospective, Multicentre, Randomised Controlled Clinical Study

NCT05381636 ·Status: UNKNOWN ·Phase: PHASE2

The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer

NCT05547529 ·Status: RECRUITING ·Phase: PHASE3

Precisely Estimation of the Prognostic Value of Lymph Node in ESCC

NCT04764240 ·Status: COMPLETED

Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma

NCT06642506 ·Status: ACTIVE_NOT_RECRUITING

Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.

NCT05900583 ·Status: UNKNOWN

UICC Classification of Esophageal Cancer

NCT01770275 ·Status: COMPLETED

RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY

NCT05570487 ·Status: UNKNOWN

Apatinib for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment

NCT02976896 ·Status: COMPLETED ·Phase: PHASE2

Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

NCT06888531 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study

NCT05028231 ·Status: UNKNOWN

Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

NCT04666090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer

NCT03301454 ·Status: TERMINATED ·Phase: PHASE2

Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCC

NCT04759235 ·Status: UNKNOWN